These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11557491

  • 21. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
    Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
    [Abstract] [Full Text] [Related]

  • 22. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
    Nilius AM, Hensey-Rudloff DM, Reimann MA, Flamm RK.
    J Antimicrob Chemother; 2002 May; 49(5):831-6. PubMed ID: 12003979
    [Abstract] [Full Text] [Related]

  • 23. Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.
    Hamilton-Miller JM, Shah S.
    J Antimicrob Chemother; 2002 Dec; 50(6):907-13. PubMed ID: 12461012
    [Abstract] [Full Text] [Related]

  • 24. In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae.
    Neuhauser MM, Jung R, Danziger LH, Pendland SL.
    Int J Antimicrob Agents; 2002 Nov; 20(5):395-8. PubMed ID: 12431879
    [No Abstract] [Full Text] [Related]

  • 25. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 26. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [Abstract] [Full Text] [Related]

  • 27. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB, Fernandes LA, Fernandes CJ.
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [Abstract] [Full Text] [Related]

  • 28. 15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibiotics.
    Shaw SJ, Abbanat D, Ashley GW, Bush K, Foleno B, Macielag M, Zhang D, Myles DC.
    J Antibiot (Tokyo); 2005 Mar; 58(3):167-77. PubMed ID: 15895524
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS, Wagner RS, Jamison T, Bell B, Stroman DW.
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Higa F, Edelstein MA.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG, DeCorby M, Noreddin A, Mendoza C, Cumming A, Nichol K, Wierzbowski A, Hoban DJ.
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A, Al-Zarouni M, Al-Najjar J, Nublusi A, Panigrahi D.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):296-302. PubMed ID: 19734608
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
    Wu Z, Lu Y, Luo M, He X, Xiao Y, Yang J, Pan Y, Qiu G, Xu Y, Huang W, Long P, Li R, Hu X.
    J Antibiot (Tokyo); 2010 Jul 01; 63(7):343-50. PubMed ID: 20448668
    [Abstract] [Full Text] [Related]

  • 39. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.
    Waites KB, Crabb DM, Duffy LB.
    Antimicrob Agents Chemother; 2003 Jan 01; 47(1):39-42. PubMed ID: 12499166
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.